1Takahashi K, Ghatei MA. Lan HC. et al. Elevated plasma endothelin in patients with diabetes melites. Diabotologia 1996; 33:306.
2Vermes I. Spoorem Mj, Kalsbeek-Batenburg EM, et al. Inaddition to von Willebrand factor and urinary albumin excreation, plasma endothelin is a indicator of endothelial dysfunction in diabetes mellitus.Diabotologia 1998; 36: 306.
3Kamoi K. Ishibashi M. T. Endothelin-1 and big endothelin-1 in NIDDM patients with and without micropathy. Diabetes Res Clin Pract 1994;24:125.
4Yasuda H. Sonobe M. Hatanaka I, et al. A new prostaglandein E1 analogue(TFC- 612) prevents adecreacase in motor conduction velocity in streptozocin-diabetic rats[J]. Biochem Biophys Res Commun 1998; 150:225 - 230.
5Shindo H. Tawata M, Tnoue M. et al. The effect of prostaglandin E1. ACD on vibratory theshould determinded with the SMV- 5 vibrometer in patients with diabetic neuropathy[J]. Diabetes Res Clin Pract 1994 ;24:173 - 180.
8Okada S, Sato K. Higuchi S. et al. Effect of prostaglandin E1 on the renin-aldosterone non-azotaemic diabetic nephropathy [J]. J Int Med Res 1998;21:126- 132.
9Okada S, Sato K, Higuchi T, et al. Influence of prostaglandin E1 on slight proteinuria in non-azotaemic diabetic[J]. Jint Med Res 1997;20:94 - 97.
10Creutzig A, Bullinger M, Cachovan M, et al. Improvement in the quality of life aftr iv. PGE1 therapy for intermittent claudication [J]. Vasa 1997;26:122 - 127
